Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
Under a Creative Commons license
open access
Abbreviations
AE
adverse event
CI
confidence interval
CRM197
cross-reactive material 197
GMR
geometric mean ratio
GMT
geometric mean titer
IPD
invasive pneumococcal disease
LLOQ
lower limit of quantitation
LOD
limit of detection
OPA
opsonophagocytic activity
PCV
pneumococcal polysaccharide conjugate vaccine
PCV7
7-valent pneumococcal conjugate vaccine
PCV13
13-valent pneumococcal conjugate vaccine
PPSV23
23-valent polysaccharide vaccine
RCDC
reverse cumulative distribution curve
SAE
serious adverse event
Keywords
Adult
Pneumococcal conjugate vaccine
Pneumonia
Cited by (0)
Copyright © 2013 The Authors. Published by Elsevier Ltd.